WahanaRiau.com - Hummingbird bioscience

Berita Politik Peristiwa Ekonomi Otomotif Olahraga Teknologi Gaya Hidup Travel Video Media OutReach Globenewswire Advertorial Pilihan Editor Terpopuler Indeks

Hummingbird bioscience

Index

Globenewswire

Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies

Rabu, 07 Januari 2026 - 05:45:36 Wib

Globenewswire

Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics

Jumat, 27 Juni 2025 - 03:26:53 Wib

Globenewswire

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Selasa, 07 Januari 2025 - 20:30:00 Wib

Globenewswire

Hummingbird Bioscience Announces Poster Presentation on HMBD-802, Novel Dual-Payload Antibody-Drug Conjugate, at EORTC-NCI-AACR 2024

Rabu, 23 Oktober 2024 - 19:30:00 Wib

Globenewswire

Hummingbird Bioscience Announces Key Leadership Appointments

Senin, 29 Juli 2024 - 19:30:00 Wib

Globenewswire

Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024

Rabu, 15 Mei 2024 - 11:52:33 Wib

Hummingbird bioscience

Hummingbird Bioscience Announces First Patient Dosed in Phase I Clinical Trial of HMBD-501 in Advanced HER3-Expressing Solid Malignancies

Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Hummingbird Bioscience Announces Poster Presentation on HMBD-802, Novel Dual-Payload Antibody-Drug Conjugate, at EORTC-NCI-AACR 2024

Hummingbird Bioscience Announces Key Leadership Appointments

Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024

Terpopuler

Bitget Partners with Market Prophit to Expand Data-Driven Social Trading Capabilities
Dibaca: 258 Kali

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction
Dibaca: 244 Kali

WillScot to Announce First Quarter 2026 Results on May 7, 2026
Dibaca: 266 Kali

Meltwater Expands YouTube Integration to Improve Creator Decisions and Campaign Performance
Dibaca: 266 Kali

State of EHS+ Technology: New Cority Research Finds 95% of EHS+ Teams Using Unapproved AI Tools, No One Trusts it to Scale
Dibaca: 292 Kali

Terkini

Bitget Partners with Market Prophit to Expand Data-Driven Social Trading Capabilities

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

WillScot to Announce First Quarter 2026 Results on May 7, 2026

Meltwater Expands YouTube Integration to Improve Creator Decisions and Campaign Performance

State of EHS+ Technology: New Cority Research Finds 95% of EHS+ Teams Using Unapproved AI Tools, No One Trusts it to Scale

Hummingbird bioscience

Terpopuler

Bitget Partners with Market Prophit to Expand Data-Driven Social Trading Capabilities Dibaca: 258 Kali

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction Dibaca: 244 Kali

WillScot to Announce First Quarter 2026 Results on May 7, 2026 Dibaca: 266 Kali

Meltwater Expands YouTube Integration to Improve Creator Decisions and Campaign Performance Dibaca: 266 Kali

State of EHS+ Technology: New Cority Research Finds 95% of EHS+ Teams Using Unapproved AI Tools, No One Trusts it to Scale Dibaca: 292 Kali

Terkini

Bitget Partners with Market Prophit to Expand Data-Driven Social Trading Capabilities
Dibaca: 258 Kali

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction
Dibaca: 244 Kali

WillScot to Announce First Quarter 2026 Results on May 7, 2026
Dibaca: 266 Kali

Meltwater Expands YouTube Integration to Improve Creator Decisions and Campaign Performance
Dibaca: 266 Kali

State of EHS+ Technology: New Cority Research Finds 95% of EHS+ Teams Using Unapproved AI Tools, No One Trusts it to Scale
Dibaca: 292 Kali